A significant association between liver dysfunction and mortality of COVID-19 patients has been also reported [41, 42], which may relate to direct viral infection (still questionable due to relatively low ACE2 expression levels in the liver [17]); to indirect damage because of drug-induced liver injury or because of COVID-19-triggered systemic inflammation [43]. Here, ACE2 is linked to COVID-19.